Literature DB >> 1673113

Genotype-phenotype relationship in various degrees of arylsulfatase A deficiency.

J Kappler1, P Leinekugel, E Conzelmann, W J Kleijer, A Kohlschütter, T Tønnesen, M Rochel, F Freycon, P Propping.   

Abstract

Arylsulfatase A (ASA) is a lysosomal enzyme that hydrolyzes sulfatide. Absence of ASA activity leads to metachromatic leukodystrophy (MLD). The clinical outcome resulting from ASA deficiency is highly variable with respect to age of onset and symptoms. So far the causes for the variability are poorly understood. We have studied the relationship between the ASA genotype and the clinical phenotype. Fibroblasts from a total of 34 subjects with low ASA activity were examined with immunoblotting, a sensitive ASA assay, and the sulfatide loading test in order to characterize low ASA activity further. By these methods, three different classes of ASA deficiency can be defined: homozygosity for the pseudodeficiency allele (ASAp), compound heterozygosity for the ASAp and MLD (ASA-) alleles, and ASA-/ASA- genotypes. These genotypes exhibit different levels of ASA residual activity. Only ASA-/ASA- genotypes are associated with MLD. For diagnostic purposes, however, the differentiation of the various ASA genotypes is essential.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673113     DOI: 10.1007/bf00194634

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  40 in total

1.  A CONTROLLED STUDY OF ENZYMIC ACTIVITIES IN THREE HUMAN DISORDERS OF GLYCOLIPID METABOLISM.

Authors:  J H AUSTIN; A S BALASUBRAMANIAN; T N PATTABIRAMAN; S SARASWATHI; D K BASU; B K BACHHAWAT
Journal:  J Neurochem       Date:  1963-12       Impact factor: 5.372

2.  [Histological methods in differential diagnosis of leukodystrophy from lipoidosis].

Authors:  T VON HIRSCH; J PEIFFER
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1955

3.  Probable metachromatic leukodystrophy/pseudodeficiency compound heterozygote at the arylsulfatase A locus with neurological and psychiatric symptomatology.

Authors:  C Hohenschutz; W Friedl; K H Schlör; A Waheed; E Conzelmann; K Sandhoff; P Propping
Journal:  Am J Med Genet       Date:  1988-09

4.  Assay for cerebroside sulfate (sulfatide) sulfatase in cultured skin fibroblasts with the natural activator protein.

Authors:  M Lee-Vaupel; E Conzelmann
Journal:  Clin Chim Acta       Date:  1987-09-15       Impact factor: 3.786

5.  Late-onset metachromatic leukodystrophy: diagnostic problems elucidated by a case report.

Authors:  D Seidel; H H Goebel; W Scholz
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

6.  A simple chromogenic assay for arylsulfatase A.

Authors:  M Lee-Vaupel; E Conzelmann
Journal:  Clin Chim Acta       Date:  1987-04-30       Impact factor: 3.786

7.  Synthesis and maturation of cross-reactive glycoprotein in fibroblasts deficient in arylsulfatase A activity.

Authors:  G Bach; E F Neufeld
Journal:  Biochem Biophys Res Commun       Date:  1983-04-15       Impact factor: 3.575

8.  Preparation of GM1 ganglioside molecular species having homogeneous fatty acid and long chain base moieties.

Authors:  S Sonnino; G Kirschner; R Ghidoni; D Acquotti; G Tettamanti
Journal:  J Lipid Res       Date:  1985-02       Impact factor: 5.922

9.  A simple and novel method for tritium labeling of gangliosides and other sphingolipids.

Authors:  G Schwarzmann
Journal:  Biochim Biophys Acta       Date:  1978-04-28
View more
  9 in total

1.  Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease.

Authors:  P Leinekugel; S Michel; E Conzelmann; K Sandhoff
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

Review 2.  "Pseudodeficiencies" of lysosomal hydrolases.

Authors:  G H Thomas
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

Review 3.  Screening for lysosomal disorders.

Authors:  K Ullrich
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

4.  Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long-term follow-up and review of the literature.

Authors:  Lucia Laugwitz; Vidiyaah Santhanakumaran; Mareike Spieker; Judith Boehringer; Benjamin Bender; Volkmar Gieselmann; Stefanie Beck-Woedl; Gernot Bruchelt; Klaus Harzer; Ingeborg Kraegeloh-Mann; Samuel Groeschel
Journal:  JIMD Rep       Date:  2022-05-04

5.  High residual arylsulfatase A (ARSA) activity in a patient with late-infantile metachromatic leukodystrophy.

Authors:  J Kreysing; W Bohne; C Bösenberg; S Marchesini; J C Turpin; N Baumann; K von Figura; V Gieselmann
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

6.  Compound heterozygosity for metachromatic leukodystrophy and arylsulfatase A pseudodeficiency alleles is not associated with progressive neurological disease.

Authors:  J M Penzien; J Kappler; N Herschkowitz; B Schuknecht; P Leinekugel; P Propping; T Tønnesen; H Lou; H Moser; S Zierz
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

7.  Functional compartments of sulphatide metabolism in cultured living cells: evidence for the involvement of a novel sulphatide-degrading pathway.

Authors:  M C Tempesta; R Salvayre; T Levade
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

8.  A missense mutation P136L in the arylsulfatase A gene causes instability and loss of activity of the mutant enzyme.

Authors:  S Kafert; U Heinisch; J Zlotogora; V Gieselmann
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

9.  Case Report: Novel Arylsulfatase A (ARSA) Gene Mutations in a Patient With Adult-Onset Metachromatic Leukodystrophy Misdiagnosed as Multiple Sclerosis.

Authors:  Lulu Xu; Meixiang Zhong; Yajuan Wang; Zhihong Wang; Jie Song; Jing Zhao; Hongyun Yu; Zhencui Yang; Wenjing Yan; Xueping Zheng
Journal:  Front Neurol       Date:  2021-01-11       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.